CHICAGO — In this video, James A. Underberg, MD, discusses recommendations from the National Lipid Association for patient-centric management of cholesterol abnormalities, and how they connect with the results of the IMPROVE-IT trial presented at the American Heart Association Scientific Sessions.
News Stories
The National Lipid Association (NLA) has just concluded several exciting days participating in the American Heart Association (AHA) Scientific Sessions 2014 in Chicago. These annual scientific sessions are the leading cardiovascular conference for basic, translational, clinical and population science in the United States and features 5,000 presentations, 1,000 invited faculty, with 4,000 abstracts presented.
Adding ezetimibe to statin therapy further lowered cholesterol levels and resulted in fewer cardiovascular events in patients following heart attack
More than a decade ago, researchers from Brigham and Women’s Hospital (BWH) demonstrated that a high dose statin, which lowered cholesterol further than a regular dose statin, provided better clinical outcomes. But questions remained about whether further reducing cholesterol would be even more effective in reducing cardiovascular-related events.